| References . | Study design . | Ethnicity . | Dialysis modality . | Gender (F/M) . | Age (years) . | Follow-up (months) . | Sample size . | Diagnosis criteria (mmol/L) . | Diagnosis method . | NODM patients/ total number (%) . | NODM incidence (n/1000 person-years) . | NOIGT patients/ total number (%) . | NOIFG patients/ total number (%) . | Risk factors for NOGMD . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cheng et al. [18] | Cohort study | Asian | CAPD | 23/12 | 43 ± 10 | 52.3 ± 35.4 | 35 | IGT: 7.78–11.11 | 2-h OGTT | NA | NA | 11/35 (31.4) | NA | High serum triglyceride |
| Woodward et al. [20] | Cohort study | American | PD | NA | NA | 24 | 5195 | DM >11.1 | NA | 150/1389 (10.7) | NA | NA | NA | NA |
| HD | 484/3806 (12.7) | NA | NA | NA | ||||||||||
| Tuzcu et al. [6] | Cohort study | Caucasian | CAPD | 19/26 | 39.6 ± 12 | 7 | 45 | DM >11; IGT 7.7–11 | 2-h OGTT | 5/45 (11.1) | NA | 6/45 (13.3) | NA | CAPD with higher LDL levels and lower insulin sensitivity compared with HD and normal group |
| HD | 23/28 | 43.3 ± 13.9 | 51 | 1/51(2.0) | NA | 2/51 (3.9) | NA | |||||||
| Szeto et al. [5] | Cohort study | Asian | CAPD | 117/135 | 59 ± 13 | 49.7 +28.4 | 252 | DM>11.1; IGT 7–11.1; IFG 5.6–7 | FBG | 12/252 (4.8) | NA | 47/252 (18.7) | 79/252 (31.4) | Impaired fasting glucose before PD. Positive correlations: age, baseline serum CRP level, Charlson comorbidity score; negative correlation: serum albumin level |
| Yu et al. [10] | Cohort study | Asian | CAPD | 85/60 | 62 ± 15 | 48 | 145 | DM>11.1; IGT 7–11.1; IFG 5.6–7 | FBG | 6/145 (4.1) | NA | 29/145 (20) | 48/145 (33.1) | High peritoneal transfer capacity; glucose load, baseline CRP and FBG level before PD. Negative correlation: D/D0 and serum albumin |
| Tien et al. [8] | Cohort study | Asian | PD | 13 984/12812 | 56.5 ± 16.6 | 53.2 | 2471 | NA | NA | 302/2471 (12.2) | NA | NA | NA | Being female, being older and having baseline comorbidities: hypertension and cardiovascular diseases |
| HD | 13 984/12812 | 56.5 ± 16.6 | 23 695 | 3044/23 695 (12.8) | NA | NA | NA | |||||||
| Chou et al. [19] | Cohort study | Asian | PD | 1632/916 | 50.2 ± 14.7 | 70 | 2548 | DM >7 | FBG twice | 351/2548 (13.8) | 24 | NA | NA | HD |
| HD | 6500/3692 | 50.3 ± 14.5 | 10 192 | 2217/10 192 (21.8) | 37 | NA | NA | |||||||
| Dong et al. [12] | Cohort study | Asian | PD | 348/264 | 55.5 ± 16.8 | 32.4 (12.9–60.8) | 612 | DM >11.1 (OGTT)/ >7 (FBG); IGT 7.8–11.1 (OGTT) | 2-h OGTT or FBG twice | 25/612 (4.1) | NA | 7/612 (1.1) | NA | Older age, higher body mass index and CRP level |
| Wang et al. [11] | Cohort study | Asian | PD | 3669/2713 | 50.4 ± 15.4 | 49.32 ± 34.2 | 6382 | NA | NA | 240/6382 (3.8) | 9.43 | NA | NA | PD |
| HD | 18 514/18365 | 62 ± 15.3 | 50.76 ± 37.8 | 36 879 | 1276/36 879 (3.5) | 5.9 | NA | NA |
| References . | Study design . | Ethnicity . | Dialysis modality . | Gender (F/M) . | Age (years) . | Follow-up (months) . | Sample size . | Diagnosis criteria (mmol/L) . | Diagnosis method . | NODM patients/ total number (%) . | NODM incidence (n/1000 person-years) . | NOIGT patients/ total number (%) . | NOIFG patients/ total number (%) . | Risk factors for NOGMD . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cheng et al. [18] | Cohort study | Asian | CAPD | 23/12 | 43 ± 10 | 52.3 ± 35.4 | 35 | IGT: 7.78–11.11 | 2-h OGTT | NA | NA | 11/35 (31.4) | NA | High serum triglyceride |
| Woodward et al. [20] | Cohort study | American | PD | NA | NA | 24 | 5195 | DM >11.1 | NA | 150/1389 (10.7) | NA | NA | NA | NA |
| HD | 484/3806 (12.7) | NA | NA | NA | ||||||||||
| Tuzcu et al. [6] | Cohort study | Caucasian | CAPD | 19/26 | 39.6 ± 12 | 7 | 45 | DM >11; IGT 7.7–11 | 2-h OGTT | 5/45 (11.1) | NA | 6/45 (13.3) | NA | CAPD with higher LDL levels and lower insulin sensitivity compared with HD and normal group |
| HD | 23/28 | 43.3 ± 13.9 | 51 | 1/51(2.0) | NA | 2/51 (3.9) | NA | |||||||
| Szeto et al. [5] | Cohort study | Asian | CAPD | 117/135 | 59 ± 13 | 49.7 +28.4 | 252 | DM>11.1; IGT 7–11.1; IFG 5.6–7 | FBG | 12/252 (4.8) | NA | 47/252 (18.7) | 79/252 (31.4) | Impaired fasting glucose before PD. Positive correlations: age, baseline serum CRP level, Charlson comorbidity score; negative correlation: serum albumin level |
| Yu et al. [10] | Cohort study | Asian | CAPD | 85/60 | 62 ± 15 | 48 | 145 | DM>11.1; IGT 7–11.1; IFG 5.6–7 | FBG | 6/145 (4.1) | NA | 29/145 (20) | 48/145 (33.1) | High peritoneal transfer capacity; glucose load, baseline CRP and FBG level before PD. Negative correlation: D/D0 and serum albumin |
| Tien et al. [8] | Cohort study | Asian | PD | 13 984/12812 | 56.5 ± 16.6 | 53.2 | 2471 | NA | NA | 302/2471 (12.2) | NA | NA | NA | Being female, being older and having baseline comorbidities: hypertension and cardiovascular diseases |
| HD | 13 984/12812 | 56.5 ± 16.6 | 23 695 | 3044/23 695 (12.8) | NA | NA | NA | |||||||
| Chou et al. [19] | Cohort study | Asian | PD | 1632/916 | 50.2 ± 14.7 | 70 | 2548 | DM >7 | FBG twice | 351/2548 (13.8) | 24 | NA | NA | HD |
| HD | 6500/3692 | 50.3 ± 14.5 | 10 192 | 2217/10 192 (21.8) | 37 | NA | NA | |||||||
| Dong et al. [12] | Cohort study | Asian | PD | 348/264 | 55.5 ± 16.8 | 32.4 (12.9–60.8) | 612 | DM >11.1 (OGTT)/ >7 (FBG); IGT 7.8–11.1 (OGTT) | 2-h OGTT or FBG twice | 25/612 (4.1) | NA | 7/612 (1.1) | NA | Older age, higher body mass index and CRP level |
| Wang et al. [11] | Cohort study | Asian | PD | 3669/2713 | 50.4 ± 15.4 | 49.32 ± 34.2 | 6382 | NA | NA | 240/6382 (3.8) | 9.43 | NA | NA | PD |
| HD | 18 514/18365 | 62 ± 15.3 | 50.76 ± 37.8 | 36 879 | 1276/36 879 (3.5) | 5.9 | NA | NA |
CRP, C-reactive protein; F, female; LDL, low-density lipoprotein; M, male; NA, not available.
| References . | Study design . | Ethnicity . | Dialysis modality . | Gender (F/M) . | Age (years) . | Follow-up (months) . | Sample size . | Diagnosis criteria (mmol/L) . | Diagnosis method . | NODM patients/ total number (%) . | NODM incidence (n/1000 person-years) . | NOIGT patients/ total number (%) . | NOIFG patients/ total number (%) . | Risk factors for NOGMD . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cheng et al. [18] | Cohort study | Asian | CAPD | 23/12 | 43 ± 10 | 52.3 ± 35.4 | 35 | IGT: 7.78–11.11 | 2-h OGTT | NA | NA | 11/35 (31.4) | NA | High serum triglyceride |
| Woodward et al. [20] | Cohort study | American | PD | NA | NA | 24 | 5195 | DM >11.1 | NA | 150/1389 (10.7) | NA | NA | NA | NA |
| HD | 484/3806 (12.7) | NA | NA | NA | ||||||||||
| Tuzcu et al. [6] | Cohort study | Caucasian | CAPD | 19/26 | 39.6 ± 12 | 7 | 45 | DM >11; IGT 7.7–11 | 2-h OGTT | 5/45 (11.1) | NA | 6/45 (13.3) | NA | CAPD with higher LDL levels and lower insulin sensitivity compared with HD and normal group |
| HD | 23/28 | 43.3 ± 13.9 | 51 | 1/51(2.0) | NA | 2/51 (3.9) | NA | |||||||
| Szeto et al. [5] | Cohort study | Asian | CAPD | 117/135 | 59 ± 13 | 49.7 +28.4 | 252 | DM>11.1; IGT 7–11.1; IFG 5.6–7 | FBG | 12/252 (4.8) | NA | 47/252 (18.7) | 79/252 (31.4) | Impaired fasting glucose before PD. Positive correlations: age, baseline serum CRP level, Charlson comorbidity score; negative correlation: serum albumin level |
| Yu et al. [10] | Cohort study | Asian | CAPD | 85/60 | 62 ± 15 | 48 | 145 | DM>11.1; IGT 7–11.1; IFG 5.6–7 | FBG | 6/145 (4.1) | NA | 29/145 (20) | 48/145 (33.1) | High peritoneal transfer capacity; glucose load, baseline CRP and FBG level before PD. Negative correlation: D/D0 and serum albumin |
| Tien et al. [8] | Cohort study | Asian | PD | 13 984/12812 | 56.5 ± 16.6 | 53.2 | 2471 | NA | NA | 302/2471 (12.2) | NA | NA | NA | Being female, being older and having baseline comorbidities: hypertension and cardiovascular diseases |
| HD | 13 984/12812 | 56.5 ± 16.6 | 23 695 | 3044/23 695 (12.8) | NA | NA | NA | |||||||
| Chou et al. [19] | Cohort study | Asian | PD | 1632/916 | 50.2 ± 14.7 | 70 | 2548 | DM >7 | FBG twice | 351/2548 (13.8) | 24 | NA | NA | HD |
| HD | 6500/3692 | 50.3 ± 14.5 | 10 192 | 2217/10 192 (21.8) | 37 | NA | NA | |||||||
| Dong et al. [12] | Cohort study | Asian | PD | 348/264 | 55.5 ± 16.8 | 32.4 (12.9–60.8) | 612 | DM >11.1 (OGTT)/ >7 (FBG); IGT 7.8–11.1 (OGTT) | 2-h OGTT or FBG twice | 25/612 (4.1) | NA | 7/612 (1.1) | NA | Older age, higher body mass index and CRP level |
| Wang et al. [11] | Cohort study | Asian | PD | 3669/2713 | 50.4 ± 15.4 | 49.32 ± 34.2 | 6382 | NA | NA | 240/6382 (3.8) | 9.43 | NA | NA | PD |
| HD | 18 514/18365 | 62 ± 15.3 | 50.76 ± 37.8 | 36 879 | 1276/36 879 (3.5) | 5.9 | NA | NA |
| References . | Study design . | Ethnicity . | Dialysis modality . | Gender (F/M) . | Age (years) . | Follow-up (months) . | Sample size . | Diagnosis criteria (mmol/L) . | Diagnosis method . | NODM patients/ total number (%) . | NODM incidence (n/1000 person-years) . | NOIGT patients/ total number (%) . | NOIFG patients/ total number (%) . | Risk factors for NOGMD . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cheng et al. [18] | Cohort study | Asian | CAPD | 23/12 | 43 ± 10 | 52.3 ± 35.4 | 35 | IGT: 7.78–11.11 | 2-h OGTT | NA | NA | 11/35 (31.4) | NA | High serum triglyceride |
| Woodward et al. [20] | Cohort study | American | PD | NA | NA | 24 | 5195 | DM >11.1 | NA | 150/1389 (10.7) | NA | NA | NA | NA |
| HD | 484/3806 (12.7) | NA | NA | NA | ||||||||||
| Tuzcu et al. [6] | Cohort study | Caucasian | CAPD | 19/26 | 39.6 ± 12 | 7 | 45 | DM >11; IGT 7.7–11 | 2-h OGTT | 5/45 (11.1) | NA | 6/45 (13.3) | NA | CAPD with higher LDL levels and lower insulin sensitivity compared with HD and normal group |
| HD | 23/28 | 43.3 ± 13.9 | 51 | 1/51(2.0) | NA | 2/51 (3.9) | NA | |||||||
| Szeto et al. [5] | Cohort study | Asian | CAPD | 117/135 | 59 ± 13 | 49.7 +28.4 | 252 | DM>11.1; IGT 7–11.1; IFG 5.6–7 | FBG | 12/252 (4.8) | NA | 47/252 (18.7) | 79/252 (31.4) | Impaired fasting glucose before PD. Positive correlations: age, baseline serum CRP level, Charlson comorbidity score; negative correlation: serum albumin level |
| Yu et al. [10] | Cohort study | Asian | CAPD | 85/60 | 62 ± 15 | 48 | 145 | DM>11.1; IGT 7–11.1; IFG 5.6–7 | FBG | 6/145 (4.1) | NA | 29/145 (20) | 48/145 (33.1) | High peritoneal transfer capacity; glucose load, baseline CRP and FBG level before PD. Negative correlation: D/D0 and serum albumin |
| Tien et al. [8] | Cohort study | Asian | PD | 13 984/12812 | 56.5 ± 16.6 | 53.2 | 2471 | NA | NA | 302/2471 (12.2) | NA | NA | NA | Being female, being older and having baseline comorbidities: hypertension and cardiovascular diseases |
| HD | 13 984/12812 | 56.5 ± 16.6 | 23 695 | 3044/23 695 (12.8) | NA | NA | NA | |||||||
| Chou et al. [19] | Cohort study | Asian | PD | 1632/916 | 50.2 ± 14.7 | 70 | 2548 | DM >7 | FBG twice | 351/2548 (13.8) | 24 | NA | NA | HD |
| HD | 6500/3692 | 50.3 ± 14.5 | 10 192 | 2217/10 192 (21.8) | 37 | NA | NA | |||||||
| Dong et al. [12] | Cohort study | Asian | PD | 348/264 | 55.5 ± 16.8 | 32.4 (12.9–60.8) | 612 | DM >11.1 (OGTT)/ >7 (FBG); IGT 7.8–11.1 (OGTT) | 2-h OGTT or FBG twice | 25/612 (4.1) | NA | 7/612 (1.1) | NA | Older age, higher body mass index and CRP level |
| Wang et al. [11] | Cohort study | Asian | PD | 3669/2713 | 50.4 ± 15.4 | 49.32 ± 34.2 | 6382 | NA | NA | 240/6382 (3.8) | 9.43 | NA | NA | PD |
| HD | 18 514/18365 | 62 ± 15.3 | 50.76 ± 37.8 | 36 879 | 1276/36 879 (3.5) | 5.9 | NA | NA |
CRP, C-reactive protein; F, female; LDL, low-density lipoprotein; M, male; NA, not available.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
